When should the β-Blocker window in cirrhosis close?

Gastroenterology

Volumn 146, Issue 7, 2014, Pages 1597-1599

  Ge, Phillip S ^a   Runyon, Bruce A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; METOPROLOL; PROPRANOLOL;

ACUTE KIDNEY FAILURE; ADRENERGIC SYSTEM; ASCITES; BACTERIAL PERITONITIS; BACTERIAL TRANSLOCATION; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CAUSE OF DEATH; CHILD PUGH SCORE; COHORT ANALYSIS; DECOMPENSATED LIVER CIRRHOSIS; DEPRESSED BLOOD PRESSURE; DISEASE COURSE; EDITORIAL; ESOPHAGUS VARICES; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GRAFT SURVIVAL; HEART INDEX; HEART OUTPUT; HEMODYNAMICS; HEPATORENAL SYNDROME; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOTENSION; HYPOVOLEMIA; INCIDENCE; LIVER CIRRHOSIS; MEAN ARTERIAL PRESSURE; MORTALITY; PARACENTESIS; PHYSIOLOGICAL STRESS; PORTAL VEIN BLOOD PRESSURE; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY PREVENTION; SODIUM RETENTION; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; UREMIA; VARICOSIS; VASOCONSTRICTION; VASODILATATION; VENOUS PRESSURE; WATER RETENTION;

ADRENERGIC BETA-ANTAGONISTS; FEMALE; HEPATORENAL SYNDROME; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; PERITONITIS;

EID: 84901228078     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.04.028     Document Type: Editorial

References (19)

1. M. Mandorfer, S. Bota, and P. Schwabl et al. Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis Gastroenterology 146 2014 1680 1690
2. D. Lebrec, T. Poynard, and P. Hillon et al. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study N Engl J Med 305 1981 1371 1374
3. J.P. Pascal, and P. Cales Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices N Engl J Med 317 1987 856 861
4. T. Sersté, C. Melot, and C. Francoz et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites Hepatology 52 2010 1017 1022
5. T. Sersté, C. Francoz, and F. Durand et al. Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study J Hepatol 55 2011 794 799
6. F. Wong, and F. Salerno Beta-blockers in cirrhosis: friend and foe? Hepatology 52 2010 811 813
7. P.S. Ge, and B.A. Runyon The changing role of beta-blocker therapy in patients with cirrhosis J Hepatol 60 2014 643 653
8. B.A. Runyon Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012 Hepatology 57 2013 1651 1653
9. A. Krag, R. Wiest, and A. Albillos et al. The window hypothesis: haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window in the disease Gut 61 2012 967 969
10. R.J. Groszmann, G. Garcia-Tsao, and J. Bosch et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis N Engl J Med 353 2005 2254 2261
11. A. Krag, F. Bendtsen, and J.H. Henriksen et al. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites Gut 59 2010 105 110
12. L. Ruiz-del-Arbol, A. Monescillo, and C. Arocena et al. Circulatory function and hepatorenal syndrome in cirrhosis Hepatology 42 2005 439 447
13. J.F. Murray, A.M. Dawson, and S. Sherlock Circulatory changes in chronic liver disease Am J Med 24 1958 358 367
14. L. Rosoff Jr., P. Zia, and T. Reynolds et al. Studies of renin and aldosterone in cirrhotic patients with ascites Gastroenterology 69 1975 698 705
15. J. Llach, P. Gines, and V. Arroyo et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites Gastroenterology 94 1988 482 487
16. R. Banares, E. Moitinho, and A. Matilla et al. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis Hepatology 36 2002 1367 1373
17. V. Arvaniti, G. D'Amico, and G. Fede et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis Gastroenterology 139 2010 1246 1256 1256 e1-5
18. L. Ruiz-del-Arbol, J. Urman, and J. Fernandez et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis Hepatology 38 2003 1210 1218
19. V. Singh, S.P. Dhungana, and B. Singh et al. Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study J Hepatol 56 2012 348 354